Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Chief Financial Officer

Senior Vice President CMC Development

Intellia pauses phase 3 CRISPR trials after patient is hospitalized

Insights Into Lipid Nanoparticle Structures Could Pave the Way to More Targeted Therapeutics

Alnylam price target raised by $125 at Cantor Fitzgerald, here's why

[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong sales growth momentum of 7% (CER) in the first nine months of 2025; full-year earnings outlook raised

Scientist, Next Wave, Target Discovery & Validation

Alnylam Pharmaceuticals is a leader in RNAi therapeutics, seeking a highly motivated scientist to join their Next Wave Target Discovery and Validation team. The role involves discovering novel therapeutic targets and collaborating with interdisciplinary teams to support RNAi-based treatments.

Principal Scientist

Senior Scientist

Sign up with Google

Sign in with Google